SCHEMBL606176

SCHEMBL606176

C[C@@H](O)[C@H](N)CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3766608 1.00
SCHEMBL26050830 1.00
SCHEMBL1704657 1.00
SCHEMBL6063689 1.00
SCHEMBL155525 1.00
SCHEMBL18622742 1.00
SCHEMBL1620911 1.00
SCHEMBL11972561 1.00
Hydrochloric Acid SCHEMBL30403161 0.97
Hydrochloric Acid SCHEMBL19642540 0.97

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 328 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260124308-A1 OLIGONUCLEOTIDES CONJUGATED TO OLEIC ACID AND USES THEREOF UNIV VALENCIA (ES) 2026-05-07 US claimed
EP-4486891-A1 OLIGONUCLEOTIDES CONJUGATED TO OLEIC ACID AND USES THEREOF Universitat de València (ES) 2025-01-08 EP claimed
US-20240425867-A1 NUCLEIC ACID-BASED ASSEMBLY AND USES THEREOF UNIV BONN RHEINISCHE FRIEDRICH WILHELMS (DE) 2024-12-26 US claimed
US-12116575-B2 Oligonucleotides conjugated to oleic acid and uses thereof UNIVERSITAT DE VALENCIA (ES) 2024-10-15 US claimed
US-20240245680-A1 Methods of Treating Retinal Vasculopathies UNITY BIOTECHNOLOGY, INC. 2024-07-25 US claimed
US-20240191276-A1 METHODS FOR LIGATION OF (POLY)PEPTIDES AND OLIGONUCLEOTIDES NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2024-06-13 US claimed
CN-117903116-A Cyclin K degrading agent 杭州阿诺生物医药科技有限公司 2024-04-19 CN claimed
CN-114401749-B Radionuclide marker and application thereof 北京拓界生物医药科技有限公司 2024-04-16 CN claimed
EP-4346813-A1 METHODS OF TREATING RETINAL VASCULOPATHIES Unity Biotechnology, Inc. (US) 2024-04-10 EP claimed
EP-4298231-A1 METHODS FOR LIGATION OF (POLY)PEPTIDES AND OLIGONUCLEOTIDES Nanyang Technological University (SG) 2024-01-03 EP claimed
CN-114805480-A Preparation method of octreotide 江苏金斯瑞生物科技有限公司 2022-07-29 CN claimed
WO-2022087385-A1 MOLECULAR DESIGNS OF GLUCOSE-RESPONSIVE AND GLUCOSE-CLEAVABLE INSULIN ANALOGUES THE TRUSTEES OF INDIANA UNIVERSITY (US) 2022-04-28 WO claimed
CN-114401749-A Radionuclide marker and application thereof 北京拓界生物医药科技有限公司 2022-04-26 CN claimed
EP-2763990-B1 PYRROLOPYRAZINE KINASE INHIBITORS HOFFMANN LA ROCHE (CH) 2017-02-22 EP claimed
EP-2935306-B1 LABELED OLIGONUCLEOTIDE PROBES USED FOR NUCLEIC ACID SEQUENCE ANALYSIS ROCHE DIAGNOSTICS GMBH (DE) 2016-11-30 EP claimed
US-8658646-B2 Pyrrolopyrazine kinase inhibitors HOFFMANN-LAROCHE INC. (US) 2014-02-25 US claimed
US-20120041225-A1 KIT FOR AUTOMATED RESOLVING AGENT SELECTION AND METHOD THEREOF VAIDYA NITEEN A (US) 2012-02-16 US claimed
EP-1981831-A2 KIT FOR AUTOMATED RESOLVING AGENT SELECTION AND METHOD THEREOF Vaidya, Niteen A. (US) 2008-10-22 EP claimed
WO-2007092264-A2 KIT FOR AUTOMATED RESOLVING AGENT SELECTION AND METHOD THEREOF VAIDYA NITEEN A (US) 2007-08-16 WO claimed
US-20070185346-A1 Kit for automated resolving agent selection and method thereof VAIDYA NITEEN A 2007-08-09 US claimed